Thanks.
I think the life sciences strategy is crucial right now, just because of global competitiveness when it comes to attracting talent. It's no secret that COVID caught everybody a little flat-footed, and suddenly everybody was trying to ramp up everything from testing to therapeutic development to vaccine production and so on. That led to the massive shortages that both Ms. Gladu and Ms. Amyot mentioned in their remarks.
I think step one is recognizing that this is urgent. Step two is taking stock across the country and talking to our companies, public health agencies, hospitals and others to get a sense of where the pressure points and bottlenecks are, not just today but looking down the road five or 10 years. Use that as a basis to work with the ecosystem of institutions as well as funders to help to make sure we're building a pipeline to satisfy those needs.